SEATTLE and DUNDEE, Scotland, Sept. 1, 2011 /PRNewswire/ -- Aridhia Informatics Ltd and Glencoe Software have formed a strategic partnership to create innovative products to aid the development of personalized therapies and deliver improved patient outcomes.
Anticipating an increased focus on stratified medicine in coming years, the two companies will work together to create products for the international healthcare, life and biomedical science markets using real-world clinical, genetic and research information.
Aridhia's specialist capabilities in accessing, storing and analyzing healthcare information will be brought together with Glencoe's expertise in managing, sharing and publishing large scientific datasets generated in laboratories around the world.
As part of the agreement, Scottish company Aridhia will make a major investment in Seattle-based Glencoe to further accelerate its already-rapid growth in these areas.
Both Glencoe Software and Aridhia Informatics are start-ups based on technology and expertise developed at the University of Dundee, Dundee, Scotland.
Professor Peter Downes, Principal of the University, said: "Dundee is a great place for life sciences companies, such as Aridhia and Glencoe, to do business. Their collaboration here will create jobs and further strengthen our innovation economy. It is good news for Dundee and good news for Scotland."
Professor Andrew Morris, Director of the Medical Research Institute at the University of Dundee, and co-founder of Aridhia Informatics, said: "This partnership brings together complementary strengths needed to accelerate the innovation of stratified - or personalized - medicines. Our vision is to become a world leader in providing the clinical and scientific information required for the personalized, targeted drugs and treatments of the future. The UK is a good place to do this work because of the opportunities for open innovation between NHS, a
|SOURCE Glencoe Software, Inc.|
Copyright©2010 PR Newswire.
All rights reserved